Sanofi-aventis to Develop healthFORWARD(TM) With Assistance From Innovatix

May 15, 2006, 01:00 ET from Sanofi-aventis

    BRIDGEWATER, N.J., May 15 /PRNewswire-FirstCall/ -- Sanofi-aventis, the
 world's third largest pharmaceutical company, is working with Innovatix,
 LLC to develop healthFORWARD(TM), a quality management process that focuses
 on identifying health care needs and implementing health management
 interventions, in the alternate care marketplace.
     Sanofi-aventis is eager to develop healthFORWARD(TM) with Innovatix,
 the nation's largest independent group purchasing organization (GPO)
 serving the alternate care provider market.
     The healthFORWARD(TM) program is comprised of two components. The
 Quality Management Process provides a step-by-step process, complete with
 tools and resources, designed to help achieve quality improvement
 objectives as it guides interactions in a logical and targeted manner to
 support agreed upon objectives. The Targeted Health Interventions are
 modular tools and resources to complement existing health management
 initiatives and are initially offered in three disease states:
 Cardiometabolic Risk, Type 2 Diabetes and Deep Vein Thrombosis/Pulmonary
 Embolism (DVT/PE).
     "We are excited to work with sanofi-aventis to develop
 healthFORWARD(TM) for our members and the patients they serve in the
 long-term care marketplace," said Walter S. Geba, Pharm.D., Vice President
 for Innovatix.
     With the extensive effort, research and resources Innovatix has
 invested in Type 2 Diabetes management initiatives, sanofi-aventis believes
 healthFORWARD(TM) provides supplementary and complementary health
 management momentum by identifying (and supporting) areas where additional
 improvement opportunities are recognized and addressed within their
 alternate care membership.
     About sanofi-aventis
     Sanofi-aventis is the world's third largest pharmaceutical company,
 ranking number one in Europe. Backed by a world-class R&D organization,
 sanofi-aventis is developing leading positions in seven major therapeutic
 areas: cardiovascular, thrombosis, oncology, metabolic diseases, central
 nervous system, internal medicine, and vaccines. Sanofi-aventis is listed
 in Paris (EURONEXT: SAN) and in New York (NYSE:   SNY).
     About Innovatix, LLC
     Innovatix, LLC is a full-service group purchasing organization (GPO)
 serving over 8,000 alternate care facilities throughout the United States.
 Innovatix is a joint venture between a subsidiary of the Greater New York
 Hospital Association and a subsidiary of Premier, Inc.
     Contact: Marc Greene, sanofi-aventis, 212-551-4400
     Contact: Travis Froehlich, Innovatix, LLC, 212-901-1353

SOURCE Sanofi-aventis